U.S. Medical Equipment Stock News

BATS:CBOE
BATS:CBOECapital Markets

Cboe Global Markets (CBOE) Sells Cboe Australia To TMX Group In Refocus

Cboe Global Markets (BATS:CBOE) has completed the sale of Cboe Australia to TMX Group. The transaction marks a refocusing of Cboe’s efforts on core growth areas and resource allocation. Investors now have new information on how Cboe is reshaping its regional presence and business mix. Cboe Global Markets runs exchanges and market infrastructure across asset classes, so any change to its regional footprint can matter for how you think about the business. The completed sale of Cboe Australia...
NYSE:PHIN
NYSE:PHINAuto Components

PHINIA (PHIN) Following Q2 Earnings And 2026 Outlook Update, Buy Opportunity Or Priced In?

PHINIA earnings and guidance in focus after second quarter update PHINIA (PHIN) reported second quarter 2026 results with sales of $940 million and net income of $40 million, alongside refined full year guidance for both net sales and earnings. The company now expects 2026 net sales between $3.57 billion and $3.67 billion and net earnings between $155 million and $180 million, providing a clearer earnings margin range of 4.3% to 4.9% for investors to track. See our latest analysis for...
NYSE:NOW
NYSE:NOWSoftware

Has ServiceNow (NOW) Fallen Far Enough To Justify Its Premium?

ServiceNow stock has fallen about 36.9% over the past year, yet the broader valuation checks still lean expensive rather than cheap for new buyers. Recent share price pressure has come alongside strong interest in the company’s AI platform and partnerships, which makes the current valuation read more nuanced than a simple “it has dropped a lot so it must be a bargain” story. Over the past 12 months, ServiceNow has delivered a share price decline of about 36.9%. This means the stock is...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open

Guardant Health filed a universal shelf registration statement, allowing it to issue various securities in the future. The filing gives the company flexibility to raise capital through debt, equity, or hybrid instruments as needed. This development could be used to support future financing, potential acquisitions, or balance sheet adjustments. Guardant Health, listed as NasdaqGS:GH, now has formal flexibility to raise funds through a range of securities. The stock last closed at $158.83 and...
NYSE:ARR
NYSE:ARRMortgage REITs

How ARMOUR Residential REIT’s Profit Rebound and Dividend Decision Could Impact ARMOUR Residential REIT (ARR) Investors

In July 2026, ARMOUR Residential REIT, Inc. reported that second-quarter net income rose to US$114.82 million from a net loss a year earlier, with earnings per share improving to US$0.86, while also affirming a US$0.24 August monthly dividend and confirming no additional share repurchases in the latest quarter under its long-running buyback program. Across the first half of 2026, the shift from a US$48.28 million loss to US$59.97 million in net income highlights a meaningful profitability...
NasdaqGS:APA
NasdaqGS:APAOil and Gas

Can APA (APA) Stay Undervalued Going Into Q2 Earnings?

APA stock has rallied strongly over the past few years, and the valuation checks now suggest the shares still lean cheap rather than fully priced in. With earnings expectations in focus ahead of the next report, investors are weighing how much of the recent strength is already embedded in APA's current price. APA has returned 125.1% over the past 5 years, which puts recent gains into context as a multi year rerating rather than just a short term move. Expected profit growth and margin trends...
NYSE:VRT
NYSE:VRTElectrical

Vertiv Holdings Co (VRT) Raises Guidance On AI Demand, Is The Upside Already Priced In?

Why Vertiv Holdings Co Stock Is Back in Focus Vertiv Holdings Co (VRT) is back on investors radar after the company reported second quarter 2026 results, raised full year earnings guidance, and highlighted ongoing demand tied to AI focused data center infrastructure. See our latest analysis for Vertiv Holdings Co. Vertiv Holdings Co shares jumped 8.89% in the last trading day to US$263.05, even though the 30 day share price return is down 12.47% and the 90 day share price return is down...
NasdaqGS:ECHO
NasdaqGS:ECHOMedia

EchoStar (ECHO) Stock Rallies On Profit Swing As Revenue Still Slips

EchoStar stock edged up 1.8% to US$85.63 after the Q2 release, a modest bounce for a company that has been under pressure over the past quarter. The headline this time is not a small beat on some clean earnings per share figure. It is a huge swing in reported profitability, with Q2 basic earnings per share at US$29.14 and net income at US$8.46b, in stark contrast to recent quarterly losses. Short term traders focused on the pop. Longer term investors are more likely to focus on whether this...
NYSE:KR
NYSE:KRConsumer Retailing

Can Kroger (KR) Justify Its Valuation Following Its AI Shopping And GLP 1 Health Push?

Kroger (KR) is rolling out an AI Shopping Assistant across its websites and apps, alongside a new GLP-1 Complete Support Program from Kroger Health, drawing fresh attention to how these tools might influence the stock. See our latest analysis for Kroger. Despite Kroger’s new AI Shopping Assistant and GLP-1 Complete Support Program drawing attention to its digital and health offerings, the stock’s recent momentum has softened, with the share price currently at US$58.22 and the 1-year total...
NYSE:WHR
NYSE:WHRConsumer Durables

Whirlpool (WHR) Following Q2 Earnings Is This Rebound A Buying Opportunity Or Fairly Valued

Whirlpool (WHR) is back in focus after its latest earnings announcement, which showed lower quarterly sales alongside higher net income and largely stable earnings per share in what management had flagged as a challenging market. See our latest analysis for Whirlpool. Whirlpool’s 1 day share price return of 4.56% after the Q2 release sits against a much weaker backdrop, with the year to date share price return down 47.37% and the 1 year total shareholder return down 51.93%. This signals...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

BioCryst Pharmaceuticals (BCRX) Faces A Valuation Test, Is The Undervalued Case Convincing?

BioCryst Pharmaceuticals (BCRX) stock has been under pressure recently, with the share price down about 10% over the past month and roughly flat over the past 3 months. Investors are reassessing what the current valuations imply. See our latest analysis for BioCryst Pharmaceuticals. Zooming out, BioCryst Pharmaceuticals’ recent weakness follows a strong year to date, with a 17.47% share price return since January and a more modest 5.38% total shareholder return over the past year. This...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

What CoStar Group (CSGP)'s Upgraded 2026 Outlook and ESOP Share Offering Means For Shareholders

CoStar Group, Inc. recently filed a US$75.83 million shelf registration for 2,500,000 common shares tied to an ESOP-related offering and reported second‑quarter 2026 results showing sales of US$925 million and net income of US$55 million, both higher than a year earlier. The company also lifted its 2026 revenue and profit guidance, signaling management confidence in the business after turning a year‑ago loss into a first‑half net profit. We’ll now examine how CoStar’s upgraded 2026 revenue...
NYSE:PNW
NYSE:PNWElectric Utilities

Is Pinnacle West Capital (PNW) Undervalued As Its Dividend Streak Reaches 33 Years?

Dividend milestone puts fresh focus on Pinnacle West Capital’s income profile Pinnacle West Capital (PNW) has come back onto investors’ radar after declaring a total dividend of $0.91 per share, with the stock now trading ex dividend as of 3 August 2026. The utility has raised its dividend every year since 1993. This gives it a 33 year streak that income focused investors often watch closely when assessing payout reliability and long term capital allocation discipline. See our latest analysis...
NYSE:JPM
NYSE:JPMBanks

JPMorgan Chase (JPM) Unveils $750 Billion American Dream Housing Plan

JPMorgan Chase announced a $750 billion American Dream Initiative running through 2035 focused on affordable housing and homeownership in the United States. The bank plans to finance the construction or preservation of 1 million affordable housing units and support 500,000 homebuyers, with an emphasis on first-time buyers. The initiative includes closer work with local governments and leadership roles in industry bodies such as chairing the U.S. Chamber of Commerce’s Housing Advisory...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

Why ACM Research (ACMR) Is Up 9.2% After 53% Shipment Growth And Reaffirmed 2026 Guidance

Over the past month, ACM Research reported a strong first quarter with shipment growth exceeding 53% year over year and confirmed its fiscal 2026 revenue guidance range, while analysts became more optimistic and institutional investors increased their positions. This combination of robust operational performance and heightened institutional interest appears to have strengthened confidence in ACM Research’s ability to execute on its growth plans. Now we’ll examine how ACM Research’s 53%...
NasdaqGS:HWKN
NasdaqGS:HWKNChemicals

Hawkins (HWKN) Balances Rising Sales and Higher Dividend With Softer Earnings – What Is Management Signaling?

Hawkins, Inc. reported first-quarter 2026 results, with sales rising to US$315.68 million from US$293.27 million a year earlier, while net income eased to US$28.25 million from US$29.18 million and diluted EPS from continuing operations slipped to US$1.35 from US$1.40. At the same meeting on July 29, 2026, the Board raised the quarterly cash dividend by 5% to US$0.20 per share, highlighting management’s willingness to increase shareholder payouts despite slightly lower earnings. We’ll now...
NYSE:CLF
NYSE:CLFMetals and Mining

Cleveland Cliffs (CLF) On Q2 Earnings And CFO Promotion Looks Slightly Undervalued

Cleveland-Cliffs (CLF) has landed on investor watchlists after second quarter 2026 results showed higher sales and a smaller net loss, alongside the promotion of CFO Celso Goncalves to President and CFO. See our latest analysis for Cleveland-Cliffs. Cleveland-Cliffs' recent results and leadership changes come after a mixed share price stretch, with the stock up 13.79% on a 1 month share price basis but still down 17.50% year to date, while the 1 year total shareholder return of 16.27%...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave (CRWV) Stock Looks Cheap On Sales But Weak On Broader Checks

CoreWeave stock has climbed 27.4% over the past week, yet its low overall valuation score and recent share price history leave investors debating whether this latest rebound offers real value or just less downside. The 27.4% gain in the past week highlights how quickly sentiment around CoreWeave can shift, which can make short term pricing less anchored to fundamentals. Recent partnerships with defense, trading and AI avatar customers may support revenue expectations, while higher borrowing...
NYSE:HNGE
NYSE:HNGEHealthcare

Circle Stock And 2 Fast Growth Picks With Strong Insider Ownership

With manufacturing, inflation and bond markets all sending mixed but gradually stabilising signals from Europe to Asia, many investors are looking for companies where insiders have meaningful skin in the game and growth expectations remain optimistic. The Fast Growing Stocks With High Insider Ownership screener focuses on exactly that combination, which can help you concentrate on businesses where management and analysts share a constructive outlook. In this article you will see three stocks...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Is Rigetti Computing's (RGTI) TangleLab Deal Quietly Reframing Its Hybrid Quantum Advantage?

Rigetti Computing recently announced that it will partner with HPE and the Pittsburgh Supercomputing Center to build the NSF-funded TangleLab hybrid quantum-classical supercomputing testbed, centered on a 9-qubit Novera system at PSC’s new data center. This collaboration strengthens Rigetti’s role in hybrid high-performance computing and expands hands-on access to its technology for researchers, educators, and public sector users. Next, we’ll examine how this TangleLab partnership with HPE...
NYSE:SM
NYSE:SMOil and Gas

Is SM Energy (SM) Still Below Fair Value As Earnings Expectations Build?

Why SM Energy’s Upcoming Earnings Report Matters SM Energy (SM) heads into its August 5 earnings report with a history of beating expectations and current indicators pointing to another possible surprise, which has pushed the stock firmly into focus. See our latest analysis for SM Energy. SM Energy’s share price has climbed 18.92% over the past 30 days and 66.91% year to date, while the 5 year total shareholder return of 87.23% contrasts with a 3 year total shareholder return decline of...
NYSE:SMG
NYSE:SMGChemicals

Scotts Miracle-Gro’s (SMG) Margin Squeeze: Does a Steady Dividend Mask Deeper Profitability Strains?

In its recently reported results for the quarter and nine months ended June 27, 2026, Scotts Miracle-Gro posted slightly higher sales of US$1,172.1 million and US$2,986.1 million respectively, but lower net income of US$112.2 million and US$225.8 million compared with the prior-year periods, while also affirming a US$0.66 per-share cash dividend payable in September 2026. The combination of rising revenue but weaker profitability highlights cost and margin pressures that could be...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Does Viking’s Expanded Shelf and ATM Funding Shift the Bull Case For Viking Therapeutics (VKTX)?

In late July 2026, Viking Therapeutics reported a wider Q2 net loss of US$128.02 million and filed both a universal shelf registration and a US$500 million at-the-market common stock offering, expanding its potential funding options across multiple security types. At the same time, upbeat analyst commentary on obesity drug candidate VK2735’s dosing flexibility and combination potential has drawn attention to how Viking’s capital-raising moves may support the long-term development of its...
NasdaqGS:MLKN
NasdaqGS:MLKNCommercial Services

MillerKnoll (MLKN) Stock May Be Undervalued As Cash Flow Holds Up

MillerKnoll stock has delivered a 35.6% return over the past three years, yet its valuation checks and current pricing still leave room for debate about how much upside is already reflected in the share price. The 35.6% three year return suggests that patient shareholders have been rewarded. This now puts more focus on whether the current price fairly reflects the business outlook. For MillerKnoll, investor expectations around the durability of cash generation can support the current...